EUVIMEDEUVIMED entdecken
Crossref

Quantum dot-based sensors and nanotheranostics for early detection and targeted therapy for colorectal cancer

Dilpreet Singh, Raj Kamal

Nanomedicine Journal · 2026-04 · 13 (2) · 256-267

DOI: 10.22038/nmj.2025.86235.2168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanomedicine Journal, 2026-04. Verfasst von Dilpreet Singh und 1 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Colorectal cancer (CRC) remains one of the most prevalent and fatal cancers worldwide, highlighting the urgent need for the development of advanced diagnostic and therapeutic strategies.Objective(s): Quantum dots (QDs), semiconductor nanomaterials with distinctive optical properties, have emerged as promising tools in the fight against colorectal cancer (CRC).Materials and Methods: The ability of QDs to emit tunable fluorescence, combined with their small size and potential for surface functionalization, enables high sensitivity and specificity in early detection and targeted treatment. In the context of CRC, QDs can be used to identify biomarkers such as carcinoembryonic antigen (CEA) and folate receptors, facilitating non-invasive imaging with high resolution.

Results

Furthermore, QDs can be functionalized for targeted therapy, enhancing the selective delivery of chemotherapeutic agents to tumor sites, reducing systemic toxicity, and allowing real-time monitoring of treatment efficacy. Despite these advantages, the clinical application of QDs in CRC is limited by challenges, including toxicity, biocompatibility, long-term stability, and efficient targeting. This review examines the current state of quantum dot-based technologies in CRC diagnostics and therapy, emphasizing their potential as nanotheranostic platforms. We also address the key barriers to clinical translation and propose future research directions to improve quantum dots' safety, efficiency, and clinical utility in CRC management.

Conclusion

Ultimately, quantum dots offer significant potential to revolutionize the diagnosis and treatment of colorectal cancer, paving the way for more personalized and effective patient care.

Schlagwörter

colorectal neoplasmsquantum dotsnanoparticlesnanotheranosticstargeted therapyearly detection

Zitieren

APA

Singh, D., & Kamal, R. (2026). Quantum dot-based sensors and nanotheranostics for early detection and targeted therapy for colorectal cancer. Nanomedicine Journal, 13(2), 256-267. https://doi.org/10.22038/nmj.2025.86235.2168

Vancouver

Singh D, Kamal R. Quantum dot-based sensors and nanotheranostics for early detection and targeted therapy for colorectal cancer. Nanomedicine Journal. 2026;13(2):256-267. doi:10.22038/nmj.2025.86235.2168

BibTeX
@article{Singh2026,
  author = {Singh, Dilpreet and Kamal, Raj},
  title = {Quantum dot-based sensors and nanotheranostics for early detection and targeted therapy for colorectal cancer},
  journal = {Nanomedicine Journal},
  year = {2026},
  volume = {13},
  number = {2},
  pages = {256--267},
  doi = {10.22038/nmj.2025.86235.2168}
}
Kostenlos starten →